Want to join the conversation?
$ALXN received FDA approval for Strensiq (asfotase alfa) to treat patients with perinatal-, infantile- and juvenile-onset hypophosphatasia (HPP). HPP is genetic, chronic, and progressive ultra-rare metabolic disease that devastate effects on multiple systems of body, leading to debilitating or life-threatening complications.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!